Involvement of Lipophagy and Chaperone-Mediated Autophagy in the Pathogenesis of Non-Alcoholic Fatty Liver Disease by Regulation of Lipid Droplets.
chaperone-mediated autophagy
lipophagy
non-alcoholic fatty liver disease
perilipins
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
02 Nov 2023
02 Nov 2023
Historique:
received:
09
10
2023
revised:
30
10
2023
accepted:
30
10
2023
medline:
15
11
2023
pubmed:
14
11
2023
entrez:
14
11
2023
Statut:
epublish
Résumé
Non-alcoholic fatty liver disease (NAFLD) is defined as the accumulation of lipids in the form of lipid droplets in more than 5% of hepatocytes. It is regarded as a range of diverse pathologies, including simple steatosis and steatohepatitis. The structural characteristics of lipid droplets, along with their protein composition, mainly including perilipins, have been implicated in the etiology of the disease. These proteins have garnered increasing attention as a pivotal regulator since their levels and distinct expression appear to be associated with the progression from simple steatosis to steatohepatitis. Perilipins are target proteins of chaperone-mediated autophagy, and their degradation is a prerequisite for lipolysis and lipophagy to access the lipid core. Both lipophagy and chaperone-mediated autophagy have significant implications on the development of the disease, as evidenced by their upregulation during the initial phases of simple steatosis and their subsequent downregulation once steatosis is established. On the contrary, during steatohepatitis, the process of chaperone-mediated autophagy is enhanced, although lipophagy remains suppressed. Evidently, the reduced levels of autophagic pathways observed in simple steatosis serve as a defensive mechanism against lipotoxicity. Conversely, in steatohepatitis, chaperone-mediated autophagy fails to compensate for the continuous generation of small lipid droplets and thus cannot protect hepatocytes from lipotoxicity.
Identifiants
pubmed: 37958873
pii: ijms242115891
doi: 10.3390/ijms242115891
pmc: PMC10649352
pii:
doi:
Substances chimiques
Perilipins
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Cell Death Dis. 2022 Feb 8;13(2):132
pubmed: 35136038
Diabetologia. 2010 Sep;53(9):1971-5
pubmed: 20461355
Nat Rev Gastroenterol Hepatol. 2017 Jun;14(6):343-355
pubmed: 28428634
Mol Cells. 2020 Aug 31;43(8):686-693
pubmed: 32624503
Liver Int. 2020 Oct;40(10):2427-2438
pubmed: 32339374
J Cell Sci. 2022 Mar 1;135(5):
pubmed: 35260890
Expert Rev Gastroenterol Hepatol. 2011 Apr;5(2):159-66
pubmed: 21476911
Crit Rev Biochem Mol Biol. 2014 Jul-Aug;49(4):304-26
pubmed: 25039762
Front Cell Dev Biol. 2019 Sep 10;7:185
pubmed: 31552248
Histopathology. 2013 Mar;62(4):617-31
pubmed: 23347084
Front Endocrinol (Lausanne). 2021 Feb 01;11:601627
pubmed: 33597924
J Hepatol. 2019 Mar;70(3):531-544
pubmed: 30414863
Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(12):G950-63
pubmed: 24157968
Dig Dis Sci. 2016 May;61(5):1304-13
pubmed: 26725058
Hepatology. 2008 Jun;47(6):1936-46
pubmed: 18393390
Hepatology. 2015 Mar;61(3):870-82
pubmed: 25179419
Mol Biol Cell. 2004 Nov;15(11):4829-40
pubmed: 15331765
Lipids Health Dis. 2017 Apr 28;16(1):83
pubmed: 28454542
Hepatology. 2007 Oct;46(4):1081-90
pubmed: 17654743
Front Cell Dev Biol. 2021 Apr 15;9:657389
pubmed: 33937257
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Cell Metab. 2012 Mar 7;15(3):279-91
pubmed: 22405066
Curr Protoc Cell Biol. 2006 Jan;Chapter 3:Unit 3.15
pubmed: 18228483
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Oct;1862(10 Pt B):1221-1232
pubmed: 28754637
Drugs. 2015 Aug;75(12):1373-92
pubmed: 26201461
Cell Death Dis. 2014 Apr 17;5:e1179
pubmed: 24743734
Sci Rep. 2019 May 6;9(1):6909
pubmed: 31061399
Hepatology. 2010 Nov;52(5):1836-46
pubmed: 21038418
Biochim Biophys Acta. 2016 Apr;1861(4):269-84
pubmed: 26778751
Gastroenterology. 1998 Apr;114(4):842-5
pubmed: 9547102
Front Endocrinol (Lausanne). 2019 Jan 31;9:778
pubmed: 30766511
Hepatology. 2021 Feb;73(2):833-842
pubmed: 32780879
J Clin Endocrinol Metab. 2006 Apr;91(4):1446-52
pubmed: 16449340
Hepatology. 2015 Jun;61(6):1896-907
pubmed: 25565581
Autophagy. 2016;12(2):432-8
pubmed: 26902588
Sci Rep. 2016 Dec 06;6:38310
pubmed: 27922115
J Biol Chem. 2014 Dec 19;289(51):35111-23
pubmed: 25342746
Annu Rev Cell Dev Biol. 2017 Oct 6;33:491-510
pubmed: 28793795
Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):E705-14
pubmed: 22331875
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):397-411
pubmed: 28487545
FEBS J. 2016 Jul;283(13):2403-13
pubmed: 26854402
Cells. 2022 Aug 17;11(16):
pubmed: 36010638
Cell Rep. 2017 Apr 4;19(1):1-9
pubmed: 28380348
Metabolism. 2016 Aug;65(8):1038-48
pubmed: 26823198
Clin Liver Dis. 2009 Nov;13(4):545-63
pubmed: 19818304
Antioxidants (Basel). 2020 Sep 27;9(10):
pubmed: 32992548
J Hepatol. 2020 Jul;73(1):202-209
pubmed: 32278004
Cells. 2019 Oct 24;8(11):
pubmed: 31652893
Hepatology. 2007 Jun;45(6):1366-74
pubmed: 17476695
Cancers (Basel). 2019 Mar 19;11(3):
pubmed: 30893876
Front Cell Dev Biol. 2021 Jun 01;9:670273
pubmed: 34141709
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221114178
pubmed: 36131551
J Hepatol. 2014 Mar;60(3):633-42
pubmed: 24269473
Nat Rev Mol Cell Biol. 2017 Nov;18(11):671-684
pubmed: 28852221
J Cell Biol. 2019 Oct 7;218(10):3320-3335
pubmed: 31391210
Mol Metab. 2021 Aug;50:101115
pubmed: 33186758
Int J Mol Sci. 2021 May 17;22(10):
pubmed: 34067931
Int J Mol Sci. 2017 May 19;18(5):
pubmed: 28534819
Autophagy. 2017 Jul 3;13(7):1130-1144
pubmed: 28548876
Diabetol Metab Syndr. 2020 Jul 14;12:60
pubmed: 32684985
Front Physiol. 2020 Jul 17;11:850
pubmed: 32765301
Annu Rev Pathol. 2016 May 23;11:451-96
pubmed: 26980160
J Hepatol. 2011 Sep;55(3):654-659
pubmed: 21172393
Clin Biochem. 2015 Sep;48(13-14):923-30
pubmed: 26151226
Gastroenterology. 2016 Jun;150(8):1769-77
pubmed: 26928243
Nat Cell Biol. 2015 Jun;17(6):759-70
pubmed: 25961502
Gastroenterology. 2005 Jul;129(1):113-21
pubmed: 16012941
Int J Hepatol. 2021 Apr 22;2021:6675762
pubmed: 33976943
Nat Rev Gastroenterol Hepatol. 2017 Mar;14(3):170-184
pubmed: 28053338
Hepatol Commun. 2019 Apr 01;3(6):776-791
pubmed: 31168512
Adv Exp Med Biol. 2018;1061:127-138
pubmed: 29956211
J Atheroscler Thromb. 2009;16(6):893-901
pubmed: 20032580
Biochem Biophys Res Commun. 2016 Aug 5;476(4):196-203
pubmed: 27208776
Endocrinology. 2005 Mar;146(3):984-91
pubmed: 15564327
Acta Gastroenterol Belg. 2020 Oct-Dec;83(4):565-570
pubmed: 33321012
J Biol Chem. 2011 Feb 18;286(7):5126-35
pubmed: 21148142
Aliment Pharmacol Ther. 2011 Aug;34(3):274-85
pubmed: 21623852
Biochim Biophys Acta. 2016 Aug;1861(8 Pt A):715-22
pubmed: 27131867
Liver Res. 2018 Sep;2(3):112-119
pubmed: 31123622
Alcohol Clin Exp Res. 2014 Feb;38(2):327-35
pubmed: 24117505
Hepatology. 2019 Dec;70(6):1885-1888
pubmed: 31520407
Am J Physiol Endocrinol Metab. 2017 Dec 1;313(6):E699-E709
pubmed: 28851734
Ann Hepatol. 2020 Sep - Oct;19(5):516-522
pubmed: 32553647
Cell Metab. 2014 Sep 2;20(3):417-32
pubmed: 25043815
Obes Surg. 2023 Mar;33(3):813-820
pubmed: 36694089
Nat Med. 2018 Jul;24(7):908-922
pubmed: 29967350
Aliment Pharmacol Ther. 2012 Nov;36(9):815-23
pubmed: 22966992
Nat Commun. 2013;4:1594
pubmed: 23481402
Gastroenterology. 2003 Aug;125(2):437-43
pubmed: 12891546
J Clin Invest. 2005 May;115(5):1343-51
pubmed: 15864352
Am J Physiol Cell Physiol. 2010 Apr;298(4):C776-85
pubmed: 20089931
J Biol Chem. 2009 Nov 6;284(45):31484-92
pubmed: 19758991
Hepatol Res. 2014 Jul;44(7):779-87
pubmed: 23773367
Front Pharmacol. 2016 Feb 24;7:33
pubmed: 26941644
J Lipid Res. 2013 May;54(5):1346-59
pubmed: 23402988